According to Apellis Pharmaceuticals's latest financial reports the company's total liabilities are $0.59 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $0.59 B | 0.65% |
2022-12-31 | $0.59 B | -13.58% |
2021-12-31 | $0.68 B | -9.64% |
2020-12-31 | $0.75 B | 112.95% |
2019-12-31 | $0.35 B | 734.14% |
2018-12-31 | $42.56 M | 28.24% |
2017-12-31 | $33.18 M | 812.04% |
2016-12-31 | $3.63 M | 13.71% |
2015-12-31 | $3.2 M | 195.89% |
2014-12-31 | $1.08 M | 59.76% |
2013-12-31 | $0.67 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $27.91 M | -95.30% | ๐บ๐ธ USA |